Home > Services > Clinical Research Studies > Clinical Trials Details
<< Back to Results
This partially randomized phase III trial studies different combinations of risk-adapted chemotherapy regimens and their side effects and comparing how well they work in treating younger patients with newly diagnosed standard-risk acute lymphoblastic leukemia or B-lineage lymphoblastic lymphoma that is found only in the tissue or organ where it began (localized). Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy), giving the drugs in different doses, and giving the drugs in different combinations may kill more cancer cells.
Contact Phone: 218-786-3308 | 1-844-681-7944
Locations: Essentia Health Cancer Centers
For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.